Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2011

01.06.2011 | Original Article

Transition of young adults with phenylketonuria from pediatric to adult care

verfasst von: Ulrike Mütze, Annika Roth, Johannes F. W. Weigel, Skadi Beblo, Christoph G. Baerwald, Peter Bührdel, Wieland Kiess

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Transition from pediatric to adult health care is a particularly vulnerable period for patients with inborn metabolic diseases. Aim of the present study was to evaluate the current transition situation of patients with phenylketonuria (PKU) in Leipzig, Germany, by analysis of the medical care, metabolic control, patients’ satisfaction, socio-economic and psychosocial status, in order to identify areas of weakness and potential improvement.

Methods

Patients who had been transferred from pediatric to adult medical care between 2005 and 2008 were identified. An interview was performed using a questionnaire. Pediatric case notes and the present physician’s case notes were analyzed retrospectively. Socio-demographic data were compared to data derived from the annual statistics of the city of Leipzig, Germany in 2008.

Results

seventy two transferred patients were identified and included in the study, 48 patients responded to the questionnaire, the data of 24 non-responders were analysed retrospectively. About 90% of the responding patients with PKU were satisfied with the current transition situation. However, they agreed to several suggestions of improvement. Most specifically an interdisciplinary appointment before the definite transfer to the adult clinics was asked for. At the time of transition, most of the patients were in good metabolic control according to current treatment guidelines (median dried blood phenylalanine concentration 853 μmol/l before versus 690 μmol/l after transition). Of the interviewed patients 92% were still on a low phenylalanine diet in combination with the intake of a phenylalanine free amino acid mixture. Of the interviewees 77% carried a secondary school certificate or a secondary modern school qualification, but only 19% had achieved senior high school diploma (controls 38.2%). Marital status was comparable with the population of Leipzig. However, fewer patients with PKU had children (15% versus 37%).

Conclusion

Transition of patients with PKU from pediatric to adult care seems to be successful in Leipzig. Patients were mostly satisfied with the transition situation. Still, some suggestions for improvements appeared to be desirable. During transition medical care and metabolic control were stable. However, with regard to psychosocial and socioeconomic data differences to the control population were detected.
Literatur
Zurück zum Zitat Acosta PB, Yannicelli S, Marriage B et al. (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287–291PubMedCrossRef Acosta PB, Yannicelli S, Marriage B et al. (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287–291PubMedCrossRef
Zurück zum Zitat Bik-Multanowski M, Didycz B, Mozrzymas R et al. (2008) Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis 29 Bik-Multanowski M, Didycz B, Mozrzymas R et al. (2008) Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis 29
Zurück zum Zitat Blau N, Bélanger-Quintana A, Demirkol M et al. (2010) Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab 99:109–115PubMedCrossRef Blau N, Bélanger-Quintana A, Demirkol M et al. (2010) Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab 99:109–115PubMedCrossRef
Zurück zum Zitat Blum R (2002) Improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics 110:1301–1303PubMed Blum R (2002) Improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics 110:1301–1303PubMed
Zurück zum Zitat Blum RW, Garell D, Hodgman CH et al. (1993) Transition from child-centered to adult health-care systems for adolescents with chronic conditions: a position paper for the Society of Adolescent Medicine. J Adolesc Health 14:570–576PubMedCrossRef Blum RW, Garell D, Hodgman CH et al. (1993) Transition from child-centered to adult health-care systems for adolescents with chronic conditions: a position paper for the Society of Adolescent Medicine. J Adolesc Health 14:570–576PubMedCrossRef
Zurück zum Zitat Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30:29–34PubMedCrossRef Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30:29–34PubMedCrossRef
Zurück zum Zitat Bremer HJ, Bührdel P. Burgard, P, et al. (1997) Therapie von Patienten mit Phenylketonurie, Empfehlungen der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS) (German) MschrKinderheilk 145:961-962 Bremer HJ, Bührdel P. Burgard, P, et al. (1997) Therapie von Patienten mit Phenylketonurie, Empfehlungen der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS) (German) MschrKinderheilk 145:961-962
Zurück zum Zitat Burgard P, Armbruster M, Schmitdt E, Rupp A (1994) Psychopathology of patients treated early for phenylketonuria: results of the German collabrorative study of phenylkotonuria. Acta Paediatr Suppl 407:108–110PubMedCrossRef Burgard P, Armbruster M, Schmitdt E, Rupp A (1994) Psychopathology of patients treated early for phenylketonuria: results of the German collabrorative study of phenylkotonuria. Acta Paediatr Suppl 407:108–110PubMedCrossRef
Zurück zum Zitat Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155(Suppl 1):S33–S38PubMedCrossRef Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155(Suppl 1):S33–S38PubMedCrossRef
Zurück zum Zitat Busse FP, Hiermann P, Galler A et al. (2007) Evaluation of patients´ opinion and metabolic control after transfer of young adults with type 1 diabetes from a pediatric diabetes clinic to adult care. Horm Res 67:132–138PubMedCrossRef Busse FP, Hiermann P, Galler A et al. (2007) Evaluation of patients´ opinion and metabolic control after transfer of young adults with type 1 diabetes from a pediatric diabetes clinic to adult care. Horm Res 67:132–138PubMedCrossRef
Zurück zum Zitat Callahan ST, Winitzer RF, Keenan P (2001) Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr 13:310–316PubMedCrossRef Callahan ST, Winitzer RF, Keenan P (2001) Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr 13:310–316PubMedCrossRef
Zurück zum Zitat Ceglarek U, Müller P, Stach B, Bührdel P, Thiery J, Kiess W (2002) Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med 40:693–697PubMedCrossRef Ceglarek U, Müller P, Stach B, Bührdel P, Thiery J, Kiess W (2002) Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med 40:693–697PubMedCrossRef
Zurück zum Zitat Channon S, Goodman G, Zlotowitz S, Mockler C, Lee PJ (2007) Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch Dis Child 92:213–218PubMedCrossRef Channon S, Goodman G, Zlotowitz S, Mockler C, Lee PJ (2007) Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch Dis Child 92:213–218PubMedCrossRef
Zurück zum Zitat Dobbelaere D, Michaud L, Debrabander A et al. (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylkatonuria. J Inherit Metab Dis 26:1–11PubMedCrossRef Dobbelaere D, Michaud L, Debrabander A et al. (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylkatonuria. J Inherit Metab Dis 26:1–11PubMedCrossRef
Zurück zum Zitat Feillet F, MacDonald A, Hartung D, Burton B (2010) Outcomes beyond phenylalanine: An international perspective. Mol Genet Metab 99:S79–S85PubMedCrossRef Feillet F, MacDonald A, Hartung D, Burton B (2010) Outcomes beyond phenylalanine: An international perspective. Mol Genet Metab 99:S79–S85PubMedCrossRef
Zurück zum Zitat Bundesministerium für Bildung und Forschung (2006) Die wirtschaftliche und soziale Lage der Studierenden in der Bundesrepublik Deutschland 2006 S3 Bundesministerium für Bildung und Forschung (2006) Die wirtschaftliche und soziale Lage der Studierenden in der Bundesrepublik Deutschland 2006 S3
Zurück zum Zitat Gassió R, Fusté E, López-Sala A, Artuch R, Vilaseca MA, Campistol J (2005) School performance in early and continuously treated phenylketonuria. Pediatr Neurol 33:267–271PubMedCrossRef Gassió R, Fusté E, López-Sala A, Artuch R, Vilaseca MA, Campistol J (2005) School performance in early and continuously treated phenylketonuria. Pediatr Neurol 33:267–271PubMedCrossRef
Zurück zum Zitat Griffiths PV, Demellweek C, Fay N, Robinson PH, Davidson DC (2000) Wechsler subscale IQ and subtest profile in early treated phenylketonuria. Arch Dis Child 82:209–215PubMedCrossRef Griffiths PV, Demellweek C, Fay N, Robinson PH, Davidson DC (2000) Wechsler subscale IQ and subtest profile in early treated phenylketonuria. Arch Dis Child 82:209–215PubMedCrossRef
Zurück zum Zitat Hardelid P, Cortina-Borja M, Munro A et al. (2008) The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England. Ann Hum Genet 72:65–71PubMed Hardelid P, Cortina-Borja M, Munro A et al. (2008) The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England. Ann Hum Genet 72:65–71PubMed
Zurück zum Zitat Henrich G, Herschbach P (2000) Questions on life satisfaction (FLZM). EJPA 16:150–159 Henrich G, Herschbach P (2000) Questions on life satisfaction (FLZM). EJPA 16:150–159
Zurück zum Zitat Hoeks MPA, den Heijer M, Janssen MCH (2009) Adult issues in phenylketonuria. Neth J Med 67:2–7PubMed Hoeks MPA, den Heijer M, Janssen MCH (2009) Adult issues in phenylketonuria. Neth J Med 67:2–7PubMed
Zurück zum Zitat Huemer M, Huemer C, Mösliner D, Huter D, Stöckler-Ipsiroglu S (2007) Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis 30:694–699PubMedCrossRef Huemer M, Huemer C, Mösliner D, Huter D, Stöckler-Ipsiroglu S (2007) Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis 30:694–699PubMedCrossRef
Zurück zum Zitat Jordan A, McDonagh J (2006) Transition: getting it right for young people. Clin Med 6:497–500PubMed Jordan A, McDonagh J (2006) Transition: getting it right for young people. Clin Med 6:497–500PubMed
Zurück zum Zitat Landolt MA, Nuoffer JM, Steinmann B, Superti-Furga A (2002) Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 140:516–521PubMedCrossRef Landolt MA, Nuoffer JM, Steinmann B, Superti-Furga A (2002) Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 140:516–521PubMedCrossRef
Zurück zum Zitat MacDonald A, Asplin D (2006) Phenylketonuria: practical dietary management. J Fam Health Care 16:83–85PubMed MacDonald A, Asplin D (2006) Phenylketonuria: practical dietary management. J Fam Health Care 16:83–85PubMed
Zurück zum Zitat MacDonald A, Davies P, Daly A et al. (2008) Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria? J Hum Nutr Diet 21:351–358PubMedCrossRef MacDonald A, Davies P, Daly A et al. (2008) Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria? J Hum Nutr Diet 21:351–358PubMedCrossRef
Zurück zum Zitat MacLeod EL, Gleason ST, van Calcar SC, Ney DM (2009) Reassessment of phenylalanine tolerance in adults with phenylaketonuria is needed as body mass changes. Mol Genet Metab 98:331–337PubMedCrossRef MacLeod EL, Gleason ST, van Calcar SC, Ney DM (2009) Reassessment of phenylalanine tolerance in adults with phenylaketonuria is needed as body mass changes. Mol Genet Metab 98:331–337PubMedCrossRef
Zurück zum Zitat McGill M (2002) How do we organize smooth, effective transition from paediatric to adult diabetes care? Horm Res 57:66–68PubMedCrossRef McGill M (2002) How do we organize smooth, effective transition from paediatric to adult diabetes care? Horm Res 57:66–68PubMedCrossRef
Zurück zum Zitat Michaud PA, Suris JC, Viner R (2004) The adolescent with a chronic condition. Part II: healthcare provision. Arch Dis Child 89:943–949PubMedCrossRef Michaud PA, Suris JC, Viner R (2004) The adolescent with a chronic condition. Part II: healthcare provision. Arch Dis Child 89:943–949PubMedCrossRef
Zurück zum Zitat Musson DG, Kramer WG, Foehr ED et al. (2010) Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults. Clin Ther 32:338–342PubMedCrossRef Musson DG, Kramer WG, Foehr ED et al. (2010) Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults. Clin Ther 32:338–342PubMedCrossRef
Zurück zum Zitat National Institut of Health Consensus Development Conference Statement (2005) Phenylketonuria: screening and management. J Inher Metab Dis 28(suppl1):18 National Institut of Health Consensus Development Conference Statement (2005) Phenylketonuria: screening and management. J Inher Metab Dis 28(suppl1):18
Zurück zum Zitat Schidlow DV, Fiel SB (1990) Life beyond pediatrics: transition of chronically ill adolescents from pediatric to adult health care systems. Med Clin North Am 74:1113–1120PubMed Schidlow DV, Fiel SB (1990) Life beyond pediatrics: transition of chronically ill adolescents from pediatric to adult health care systems. Med Clin North Am 74:1113–1120PubMed
Zurück zum Zitat Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16:681–688PubMedCrossRef Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16:681–688PubMedCrossRef
Zurück zum Zitat Schmidt H, Burgard P, Pietz J, Rupp A (1996) Intelligence and professional career in young adults treated early for phenylketonuria. Eur J Pediatr 155:97–100CrossRef Schmidt H, Burgard P, Pietz J, Rupp A (1996) Intelligence and professional career in young adults treated early for phenylketonuria. Eur J Pediatr 155:97–100CrossRef
Zurück zum Zitat Schwarz M, Wendel U (2005) Inborn errors of metabolism (IEM) in adults: a new challenge to internal medicine. Med Klin 100:547–552CrossRef Schwarz M, Wendel U (2005) Inborn errors of metabolism (IEM) in adults: a new challenge to internal medicine. Med Klin 100:547–552CrossRef
Zurück zum Zitat Scriver CR (2007) The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 28:831–845PubMedCrossRef Scriver CR (2007) The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 28:831–845PubMedCrossRef
Zurück zum Zitat Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1998) The hyperphenylalaninemias. In: Scriver RC, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1015–1075 Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1998) The hyperphenylalaninemias. In: Scriver RC, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1015–1075
Zurück zum Zitat Simon E, Schwarz M, Roos J et al. (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 6:25PubMedCrossRef Simon E, Schwarz M, Roos J et al. (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 6:25PubMedCrossRef
Zurück zum Zitat Stadt Leipzig, Amt für Statistik und Wahlen (2008) Statistisches Jahrbuch 2008: 24, 27, 77, 82, 145 Stadt Leipzig, Amt für Statistik und Wahlen (2008) Statistisches Jahrbuch 2008: 24, 27, 77, 82, 145
Zurück zum Zitat Stemerdink BA, Kalverboer AF, van der Meere JJ et al. (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23:548–562PubMedCrossRef Stemerdink BA, Kalverboer AF, van der Meere JJ et al. (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23:548–562PubMedCrossRef
Zurück zum Zitat Unger S, Weigel JF, Stepan H, Baerwald CG (2009) A case of maternal PKU syndrome despite intensive patient counseling. Wien Med Wochenschr 159:507–510PubMedCrossRef Unger S, Weigel JF, Stepan H, Baerwald CG (2009) A case of maternal PKU syndrome despite intensive patient counseling. Wien Med Wochenschr 159:507–510PubMedCrossRef
Zurück zum Zitat Van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the needs for a new guideline. J Inherit Metab Dis 31:673–679PubMedCrossRef Van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the needs for a new guideline. J Inherit Metab Dis 31:673–679PubMedCrossRef
Zurück zum Zitat Viner R (1999) Transition from paediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 81:271–275PubMedCrossRef Viner R (1999) Transition from paediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 81:271–275PubMedCrossRef
Zurück zum Zitat Walter JH, White FJ, Hall SK et al. (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef Walter JH, White FJ, Hall SK et al. (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef
Zurück zum Zitat Zeman J, Pijackova A, Behulova J, Urge O, Saligova HJ (1996) Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak collaborative study. Eur J Pediatr 155:56–58CrossRef Zeman J, Pijackova A, Behulova J, Urge O, Saligova HJ (1996) Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak collaborative study. Eur J Pediatr 155:56–58CrossRef
Metadaten
Titel
Transition of young adults with phenylketonuria from pediatric to adult care
verfasst von
Ulrike Mütze
Annika Roth
Johannes F. W. Weigel
Skadi Beblo
Christoph G. Baerwald
Peter Bührdel
Wieland Kiess
Publikationsdatum
01.06.2011
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 3/2011
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9284-x

Weitere Artikel der Ausgabe 3/2011

Journal of Inherited Metabolic Disease 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.